Clarity enhancement disclosure is the mandatory trade and legal requirement to inform a buyer, at the point of sale, that a gemstone has undergone any treatment intended to improve its apparent clarity. Such treatments include fracture filling (with glass, resin, or flux), oil or resin impregnation, and laser drilling. The obligation applies across the supply chain — from cutter and wholesaler to retailer — and is codified by industry bodies, national trade associations, and consumer-protection law in multiple jurisdictions. Failure to disclose is classified as a deceptive trade practice and can expose a seller to legal liability as well as reputational damage within the trade.

Regulatory and Industry Framework

In the United States, the primary legal authority is the Federal Trade Commission (FTC), whose Guides for the Jewelry, Precious Metals, and Pewter Industries state that sellers must disclose any treatment that has a significant effect on a gem's value or that requires special care. The FTC's position is that a buyer cannot make an informed purchasing decision without knowing whether the apparent clarity of a stone reflects its natural condition or an artificial intervention.

The American Gem Trade Association (AGTA) reinforces this through its Source Disclosure Programme, which requires member firms to disclose all treatments — including clarity enhancements — in writing wherever practicable. The AGTA's treatment codes, published in its annual Source Disclosure guidelines, assign specific letter designations to different enhancement types (for example, F for fracture filling, O for oiling), allowing disclosure to be communicated concisely on invoices and lot descriptions.

The Gemological Institute of America (GIA) addresses the issue through its grading reports: stones submitted with detectable clarity enhancements are either declined for standard grading or issued a report that explicitly notes the presence of the treatment. A GIA report that states a stone is fracture-filled, for instance, functions as a permanent disclosure document that travels with the gem through subsequent sales.

Treatments Requiring Disclosure

The following clarity enhancements are universally recognised as requiring disclosure under AGTA, FTC, and GIA guidelines:

• Fracture filling — injection of glass, lead-glass, resin, or flux into surface-reaching fractures to reduce their visibility. Particularly prevalent in rubies and, to a lesser extent, sapphires and diamonds.
• Oil and resin impregnation — filling of surface fractures or pores with colourless or tinted oils, resins, or waxes. The standard treatment for emeralds; also applied to some tourmalines and beryls.
• Laser drilling — use of a laser to create channels to inclusions in diamonds, followed by acid bleaching or glass filling. The drilling itself, and any subsequent filling, both require disclosure.
• Polymer or epoxy impregnation — used in heavily fractured or porous stones such as certain jadeite, turquoise, and lapis lazuli specimens.

It is important to note that the degree of enhancement matters commercially but does not alter the disclosure obligation. A stone with only minor oiling must be disclosed in the same way as one with heavy fracture filling, though the trade commonly distinguishes between minor, moderate, and significant levels of treatment when describing the extent of enhancement.

Practical Application in the Trade

Disclosure is expected to be communicated in writing wherever practical — on invoices, lot descriptions, memo agreements, and retail sales receipts. Verbal disclosure alone is considered insufficient for high-value transactions. In practice, many wholesalers use the AGTA treatment codes on their invoices, while retailers are expected to translate this information into plain language for the end consumer.

Independent gemmological laboratories play a central role in substantiating disclosure. A report from GIA, Gübelin, SSEF, or Lotus Gemology that identifies a clarity enhancement provides objective, third-party confirmation that can accompany a stone through multiple ownership changes. For significant stones — particularly rubies and emeralds — buyers and auction houses routinely require a current laboratory report precisely because it serves as a reliable disclosure document.

Market Integrity and Consumer Protection

The rationale for mandatory disclosure is straightforward: clarity-enhanced stones command materially lower prices than their untreated equivalents of comparable apparent quality. A fine emerald with only minor oil filling may be worth several times more than an identical-looking stone with heavy resin impregnation. Without disclosure, a buyer has no basis on which to assess fair value, negotiate price, or make informed decisions about care — since many clarity enhancements are sensitive to heat, ultrasonic cleaning, or solvents that would be routine for an untreated stone.

Non-disclosure, whether deliberate or through ignorance of the supply chain, undermines confidence in the coloured-stone and diamond markets. The consistent enforcement of disclosure standards by trade associations and the availability of laboratory testing have together raised the baseline of transparency considerably since the 1990s, though enforcement remains imperfect in less regulated markets.

Further Reading

• FTC Guides for the Jewelry, Precious Metals, and Pewter Industries
• AGTA Gem Treatment Disclosure Policy
• GIA — Gem Treatments and Disclosure